BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16563744)

  • 1. Budding invasive margin and prognosis in colorectal cancer--no direct association with beta-catenin expression.
    Hörkkö TT; Klintrup K; Mäkinen JM; Näpänkangas JB; Tuominen HJ; Mäkelä J; Karttunen TJ; Mäkinen MJ
    Eur J Cancer; 2006 May; 42(7):964-71. PubMed ID: 16563744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
    Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
    Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour budding at invasive margins and outcome in colorectal cancer.
    Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
    Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-catenin expression in relation to genetic instability and prognosis in colorectal cancer.
    Mårtensson A; Oberg A; Jung A; Cederquist K; Stenling R; Palmqvist R
    Oncol Rep; 2007 Feb; 17(2):447-52. PubMed ID: 17203186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
    Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY
    Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.
    Chung GG; Provost E; Kielhorn EP; Charette LA; Smith BL; Rimm DL
    Clin Cancer Res; 2001 Dec; 7(12):4013-20. PubMed ID: 11751495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the cell-cell adhesion molecule beta-catenin in colorectal carcinomas and their metastases.
    Buhmeida A; Elzagheid A; Algars A; Collan Y; Syrjänen K; Pyrhönen S
    APMIS; 2008 Jan; 116(1):1-9. PubMed ID: 18254773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer.
    Kawada M; Seno H; Uenoyama Y; Sawabu T; Kanda N; Fukui H; Shimahara Y; Chiba T
    Cancer Res; 2006 Mar; 66(6):2913-7. PubMed ID: 16540637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
    Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y
    Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Pin1 expression is associated with tumor progression in colorectal cancer.
    Kuramochi J; Arai T; Ikeda S; Kumagai J; Uetake H; Sugihara K
    J Surg Oncol; 2006 Aug; 94(2):155-60. PubMed ID: 16847925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
    Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
    Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer.
    Magnusson C; Mezhybovska M; Lörinc E; Fernebro E; Nilbert M; Sjölander A
    Eur J Cancer; 2010 Mar; 46(4):826-35. PubMed ID: 20064706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma.
    Suzuki H; Masuda N; Shimura T; Araki K; Kobayashi T; Tsutsumi S; Asao T; Kuwano H
    Anticancer Res; 2008; 28(3B):1821-30. PubMed ID: 18630466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic beta-catenin accumulation is a good prognostic marker in upper and lower gastrointestinal adenocarcinomas.
    Norwood MG; Bailey N; Nanji M; Gillies RS; Nicholson A; Ubhi S; Darnton JJ; Steyn RS; Womack C; Hughes A; Hemingway D; Harrison R; Waters R; Jankowski JA
    Histopathology; 2010 Jul; 57(1):101-11. PubMed ID: 20572881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer.
    De Toni EN; Thieme SE; Herbst A; Behrens A; Stieber P; Jung A; Blum H; Göke B; Kolligs FT
    Clin Cancer Res; 2008 Aug; 14(15):4713-8. PubMed ID: 18676739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation of the beta-catenin gene at the invasion front of colorectal liver metastases.
    Bandapalli OR; Dihlmann S; Helwa R; Macher-Goeppinger S; Weitz J; Schirmacher P; Brand K
    J Pathol; 2009 Jul; 218(3):370-9. PubMed ID: 19347947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
    Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS
    Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma.
    Ohtsuki K; Koyama F; Tamura T; Enomoto Y; Fujii H; Mukogawa T; Nakagawa T; Uchimoto K; Nakamura S; Nonomura A; Nakajima Y
    Anticancer Res; 2008; 28(3B):1831-6. PubMed ID: 18630467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.
    Kudo J; Nishiwaki T; Haruki N; Ishiguro H; Shibata Y; Terashita Y; Sugiura H; Shinoda N; Kimura M; Kuwabara Y; Fujii Y
    World J Surg Oncol; 2007 Feb; 5():21. PubMed ID: 17309796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.